Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of Protein Phosphatase Non-receptor Type 11 (PTPN11) in Gastric Carcinomas

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Tyrosine phosphorylation and dephosphorylation by protein tyrosine kinases and phosphatases (PTPs), respectively, play crucial roles in cellular signal transduction. Protein phosphatase non-receptor type 11 (PTPN11) is a positive signaling PTP that activates RAS and ERK signaling. Also, the PTPN11 binds with CagA of Helicobacter pylori in gastric epithelial cells.

Aim

The aim of this study was to explore whether alteration of PTPN11 protein expression is a feature of gastric cancer cells.

Methods

We analyzed PTPN11 expression in 92 gastric cancer tissues by immunohistochemistry using a tissue microarray method.

Results

The gastric cancers expressed PTPN11 in 78 (87%) specimens, while the epithelial cells in normal gastric mucosa did not display any PTPN11 immunoreactivity. The PTPN11 expression in the cancers was associated with the tubular morphology (versus signet ring cell type), the Lauren’s intestinal type (versus diffuse type), and the advanced gastric cancer type (versus early gastric cancer type).

Conclusion

Our data indicate that gastric cancers display a higher expression of PTPN11 protein than the normal cells, suggesting that neo-expression of this positive signaling protein in the cells might play a role in the cancer development. Also, the higher expression of PTPN11 in tubular and intestinal types, where Helicobacter pylori has a definite role in the development of the cancers, suggest a possibility that PTPN11 might play a role in regulation in Helicobacter pylori pathogenesis the gastric cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ostman A, Böhmer FD. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 2001;11:258–266.

    Article  CAS  PubMed  Google Scholar 

  2. Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997;9:193–204.

    Article  CAS  PubMed  Google Scholar 

  3. Li L, Dixon JE. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin Immunol. 2000;12:75–84.

    Article  CAS  PubMed  Google Scholar 

  4. Mohi MG, Neel BG. The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev. 2007;17:23–30.

    Article  CAS  PubMed  Google Scholar 

  5. Neel BG, Gu H, Pao L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284–293.

    Article  CAS  PubMed  Google Scholar 

  6. Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature. 2001;411:355–365.

    Article  CAS  PubMed  Google Scholar 

  7. Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Comprehensive review of Noonan syndrome and its affiliated disorders, including discussion of mutational spectrum, phenotypic features and pathogenic mechanisms. Annu Rev Genomics Hum Genet. 2005;6:45–68.

    Article  CAS  PubMed  Google Scholar 

  8. Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34:148–150.

    Article  CAS  PubMed  Google Scholar 

  9. Bentires-Alj M, Paez JG, David FS, et al. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004;64:8816–8820.

    Article  CAS  PubMed  Google Scholar 

  10. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–686.

    Article  CAS  PubMed  Google Scholar 

  11. Yamazaki S, Yamakawa A, Ito Y, et al. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003;187:334–337.

    Article  CAS  PubMed  Google Scholar 

  12. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688–694.

    Article  CAS  PubMed  Google Scholar 

  13. Lee SH, Shin MS, Park WS, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene. 1999;18:3754–3760.

    Article  CAS  PubMed  Google Scholar 

  14. Zhou X, Coad J, Ducatman B, Agazie YM. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis. Histopathology. 2008;53:389–402.

    Article  CAS  PubMed  Google Scholar 

  15. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119:265–272.

    Article  CAS  PubMed  Google Scholar 

  16. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    CAS  PubMed  Google Scholar 

  17. Martín-de-Argila C, Boixeda D, Redondo C, et al. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol. 1997;32:303–307.

    Article  PubMed  Google Scholar 

  18. Trajkov D, Stardelova K, Dimitrova M, Mishevski J, Serafimoski V. Helicobacter pylori and gastric carcinoma. Prilozi. 2007;28:39–46.

    CAS  PubMed  Google Scholar 

  19. Hatakeyama M. Helicobacter pylori CagA–a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217–1223.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, College of Medicine, Uijongbu St. Mary’s Hospital, The Catholic University of Korea, 65-1 Gumoh-dong, Uijongbu, Kyunggido, Seoul, 480-717, Korea

    Jin Soo Kim, Hyung Keun Kim, Young Seok Cho & Sung Soo Kim

  2. Department of Pathology, College of Medicine, Uijongbu St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

    Ok Ran Shin

  3. Department of General Surgery, College of Medicine, Uijongbu St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

    Chang Hyeok An & Keun Woo Lim

Authors
  1. Jin Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ok Ran Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyung Keun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young Seok Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chang Hyeok An
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keun Woo Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sung Soo Kim.

Additional information

Jin Soo Kim and Ok Ran Shin contributed equally in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, J.S., Shin, O.R., Kim, H.K. et al. Overexpression of Protein Phosphatase Non-receptor Type 11 (PTPN11) in Gastric Carcinomas. Dig Dis Sci 55, 1565–1569 (2010). https://doi.org/10.1007/s10620-009-0924-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0924-z

Keywords

Search

Navigation